摘要

Objective: To evaluate renal brush border membrane enzymes in urine as an indicator for renal injury in neonatal scleredema(NS). Methods: Sixty nine NS patients in our hospital were enrolled and divided into mild group and moderate/ severe group. Patients were further randomly divided into therapy and control subgroups for 7 days ligustrazine administration. Urine samples were collected to detect renal brush border membrane enzymes (RBBME) by ELISA and beta 2-microglobulin (beta(2)-MG) by radioimmunoassay (RIA). The results were compared, with those of 30 normal neonates. Data were statistically analyzed using SPSS13.0 software., Results: Both RBBME and beta(2)-MG were found to be higher in urine in NS patients than normal controls (P < 0.01). Level of RBBME increased with the severity of NS (P <0.05), while urinary beta(2)-MG did not (P >0.05). After being treated with ligustrazine, a medicine for renal function recovery, both RBBME and beta(1)-MG were. similarly significantly decreased comparing to untreated groups (P < 0.05). 79.7% of NS patients showed abnormal RBBME while only 52.2% had an abnormal urinary beta(2)-MG (x2=11.65, P < 0.01). Conclusion: RBBME was more sensitive than 132-MG in reflecting the renal injury in NS. Examination of RBBME effectively reflected the recovery of renal injury after treatment with ligustrazine.

  • 出版日期2015-2
  • 单位聊城市人民医院

全文